TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia

Blood

Volumn 91, Issue 5, 1998, Pages 1716-1722

  Seeger, Karlheinz ^a   Adams, Hans Peter ^b   Buchwald, Dirk ^b   Beyermann, Birgit ^b   Kremens, Bernhard ^b   Niemeyer, Charlotte ^b   Ritter, Jörg ^b   Schwabe, Dirk ^b   Harms, Dörte ^b   Schrappe, Martin ^b   Henze, Günter ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; FEMALE; GENE TARGETING; GENETIC TRANSCRIPTION; HEMATOPOIETIC CELL; HIGH RISK POPULATION; HUMAN; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT;

EID: 0032032302     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.5.1716.1716_1716_1722     Document Type: Article

References (41)

1. Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Gelber R, Heerema N, Korn EL, Link M, Murphy S, Pui CH, Pullen J, Reamon G, Sallan SE, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Uckun F, Ungerleider R: Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 14:18, 1996
2. Reiter A, Schrappe M, Ludwig WD, Hiddemann W, Sauter S, Henze G, Zimmermann M, Lampert F, Havers W, Niethammer D: Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 84:3122, 1994
3. Steinherz PG, Gaynon PS, Breneman JC, Cherlow JM, Grossman NJ, Kersey JH, Johnstone HS, Sather HN, Trigg ME, Chappell R, Hammond D, Bleyer WA: Cytoreduction and prognosis in acute lymphoblastic leukemia - The importance of early marrow response: Report from the Childrens Cancer Group. J Clin Oncol 14:389, 1996
4. Rubin CM, Le Beau MM, Mick R, Bitter MA, Nachman J, Rudinsky R, Appel HJ. Morgan E, Suarez CR, Schumacher HR, Subramanian U, Rowley JD: Impact of chromosomal translocations on prognosis in childhood acute lymphoblastic leukemia. J Clin Oncol 9:2183, 1991
5. Pui CH, Frankel LS, Carroll AJ, Raimondi SC, Shuster JJ, Head DR, Crist WM, Land VJ, Pullen DJ, Steuber CP, Behm FG, Borowitz MJ: Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): A collaborative study of 40 cases. Blood 77:440, 1991
6. Raimondi SC: Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 81:2237, 1993
7. Behm FG, Raimondi SC, Frestedt JL, Liu Q, Crist WM, Downing JR, Rivera GK, Kersey JH, Pui CH: Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age. Blood 87:2870. 1996
8. Henze G, Adams HP, for the ALL-REZ BFM Study Group: Treatment of children with relapsed ALL - Studies of the BFM Study Group. Ann Hematol 74:A57, 1997 (suppl 1 )
9. Henze G: Chemotherapy for relapsed childhood acute lymphoblastic leukemia. Int J Pediatr Hematol Oncol (in press)
10. Beyermann B, Agthe AG, Adams HP, Seeger K, Linderkamp C, Goetze G, Ludwig WD, Henze G: Clinical features and outcome of children with first marrow relapse of acute lymphoblastic leukemia expressing BCR-ABL fusion transcripts. BFM Relapse Study Group. Blood 87:1532, 1996
11. Beyermann B, Adams HP, Henze G: The Philadelphia chromosome in acute lymphoblastic leukemia. A matched pair analysis. BFM Relapse Study Group. J Clin Oncol 15:2231, 1997
12. Romana SP, Poirel H, Leconiat M, Flexor MA, Mauchauffe M, Jonveaux P, Macintyre EA, Berger R, Bernard OA: High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 86:4263, 1995
13. Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML, Chan GC, Pui CH, Grosveld G, Downing JR: TEL/AML 1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 9:1985, 1995
14. Nakao M, Yokota S, Horiike S, Taniwaki M, Kashima K, Sonoda Y, Koizumi S, Takaue Y, Matsushita T, FujimotoT, Misawa S: Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia. Leukemia 10:1463, 1996
15. McLean TW, Ringold S, Neuberg D, Stegmaier K, Tantravahi R, Ritz J. Koeffler HP, Takeuchi S, Janssen JW, Seriu T, Bartram CR, Sallan SE, Gilliland DG, Golub TR: TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood 88:4252, 1996
16. Rubnitz JE, Shuster JJ, Land VJ, Link MP, Pullen J, Camitta BM, Pui CH, Downing JR, Behm FG: Case control study suggests a favorable impact of tel rearrangement in patients with B lineage acute lymphoblastic leukemia treated with antimetabolite based therapy: A Pediatric Oncology Group study. Blood 89:1143, 1997
17. Rubnitz JE, Downing JR, Pui CH, Shurtleff SA, Raimondi SC, Evans WE, Head DR, Crist WM, Rivera GK, Hancock ML, Boyett JM, Buijs A, Grosveld G, Behm FG: Tel gene rearrangement in acute lymphoblastic leukemia: A new genetic marker with prognostic significance. J Clin Oncol 15:1150, 1997
18. Borkhardt A, Cazzaniga G, Viehmann S, Valsecchi MG, Ludwig W-D, Burci L, Mangioni S, Schrappe M, Riehm M, Lampert M, Basso G, Masera G, Harbott G, Biondi A: Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Blood 90:571, 1997
19. Golub TR, Barker GF, Stegmaier K, Gilliland DG: Involvement of the TEL gene in hematologie malignancy by diverse molecular genetic mechanisms. Curr Top Microbiol Immunol 211:279, 1996
20. Sawyers CL: Molecular genetics of acute leukaemia. Lancet 349:196, 1997
21. Liang DC, Chou TB, Chen JS, Shurtleff SA, Rubnitz JE, Downing JR, Pui CH, Shih LY: High incidence of TEL/AML 1 fusion resulting from a cryptic t(12;21) in childhood B-lineage acute lymphoblastic leukemia in Taiwan. Leukemia 10:991, 1996
22. Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR: AML 1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84:321, 1996
23. Hiebert SW, Sun W, Davis JN, Golub T, Shurtleff S, Buijs A, Downing JR, Grosveld G, Roussell MF, Gilliland DG, Lenny N, Meyers S: The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Mol Cell Biol 16:1349, 1996
24. Meyers S, Lenny N, Sun W, Hiebert SW: AML-2 is a potential target for transcriptional regulation by the t(8;2l) and t(12;21) fusion proteins in acute leukemia. Oncogene 13:303, 1996
25. Golub TR, Barker GF, Lovett M, Gilliland DG: Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77:307, 1994
26. Papadopoulos P, Ridge SA, Boucher CA, Stocking C, Wiedemann LM: The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Res 55:34, 1995
27. Buijs A, Sherr S, van Baal S, van Bezouw S, van der Plas D, Geurts van Kessel A, Riegman P, Lekanne Deprez R, Zwarthoff E, Hagemeijer A, Grosveld G: Translocation (12;22)(p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. Oncogene 10:1511, 1995
28. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M: The t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Nat1 Acad Sci USA 88:10431, 1991
29. Nucifora G, Rowley JD: The AML1 gene in the 8;21 and 3;21 translocations in chronic and acute myeloid leukemia. Cold Spring Harb Symp Quant Biol 59:595, 1994
30. Henze G, Fengler R, Adams HP: ALL-REZ BFM 96 - Studie zur Behandlung von Kindern mit Rezidivi einer akuten lymphoblastischen Leukämie. Berlin, Germany, Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH), 1997
31. Hartung J: Statistik: Lehr- und Handbuch der angewandten Statisitk. München, Germany, R. Oldenbourg Verlag GmbH, 1995
32. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
33. Borgmann A, Schmid H, Hartmann R, Baumgarten E, Hermann K, Klingebiel T, Ebell W, Zintl F, Gadner H, Henze G: Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: A matchedpair analysis. The Berlin-Frankfurt-Münster Study Group. Lancet 346:873, 1995
34. Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray Ward P, Morgan E, Raimondi SC, Rowley JD, Gilliland DG: Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 92:4917, 1995
35. Schrappe M, Reiter A, Sauter S, Ludwig WD, Wormann B, Harbott J, Bender Gotze C, Dorffel W, Dopfer R, Frey E, Havers W, Henze G, Kühl J, Richter R, Ritter J, Treuner J, Zintl F, Odenwald E, Weite K, Riehm H: Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: The significance of initial therapy response in blood and bone marrow. Klin Padiatr 206:208, 1994
36. Janka-Schaub GE, Harms D, Goebel U, Graubner U, Gutjahr P, Haas RJ, Juergens H, Spaar HJ, Winkler K: Randomized comparison of rotational chemotherapy in high-risk acute lymphoblastic leukaemia of childhood - Follow up after 9 years. CoALL Study Group. Eur J Pediatr 155:640, 1996
37. Conter V, Rizzari C, Arico M, Basso G, Colella R, Dibenedetto SP, Di Tullio MT, Messina C, Miniero R, Mori PG, Pession A, Rondelli R, Silvestri D, Testi AM, Valsecchi MG, Masera G: Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Munster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica. J Clin Oncol 13:2497, 1995
38. Berger R, Leconiat M, Romana SP, Jonveaux P: Secondary acute myeloblastic leukemia with t(16;21)(q24;q22) involving the AML1 gene. Hematol Cell Ther 38:183, 1996
39. Zent C, Kim N, Hiebert S, Zhang DE, Tenen DG, Rowley JD, Nucifora G: Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: Expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic properties. Curr Top Microbiol Immunol 211:243, 1996
40. Stanulla M, Wang J, Chervinsky DS, Aplan PD: Topoisomerase II inhibitors induce DNA double-strand breaks at a specific site within the AML 1 locus. Leukemia 11:490, 1997
41. Aplan PD, Chervinsky DS, Stanulla M, Burhans WC: Sitespecific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors. Blood 87:2649, 1996